
O-111 Docetaxel and COX-2 inhibition with celecoxib in progressive non-small cell lung cancer (NSCLC): Promising progression-free survival in a phase II study
Nugent, Francis W., Graziano, Stephen, Collea, Rufus, Levitan, Nathan, Gajra, Ajeet, Freeman, John, O'Connell, Cathy, Marshall, Janine, Mertens, Wilson, McCann, JohnVolume:
41
Langue:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(03)91769-7
Date:
August, 2003
Fichier:
PDF, 367 KB
english, 2003